AKT1 and vitiligo: (39) found that apigenin reduced the apoptosis of melanocytes induced by dopamine, a trigger of oxidative stress, by inhibiting the phosphorylation of p38, JNK and Akt, suggesting its potential as a drug candidate for vitiligo treatment.